RIP3 deletion affords more protection than MLKL deficiency in mouse models of renal injury, metastatic tumor, TNF-α challenge, arthritis and infection, supporting other non-necroptotic roles for RIP316,63–65. This evidence concerns the gene TNF and metastatic neoplasm.